Same Indication

Montelukast vs Trastuzumab

Montelukast vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Montelukast and Trastuzumab.

Mechanism of Action

Montelukast: Selective leukotriene D4 receptor antagonist.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Montelukast — 2.7-5.5 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Montelukast — C35H36ClNO3S.

Molecular Weight: Montelukast — 586.1800 g/mol.

Type: Montelukast — Small molecule; Trastuzumab — Antibody.